BGM Group Ltd. (BGM): EPS (Diluted)
-$0.18
Year ended 2025-09-30
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$0.18 | n/m | 2026-07-21, From 2024-10-01 |
| 2024-09-30 | -$0.20 | n/m | 2026-07-21, From 2023-10-01 |
| 2023-09-30 | -$1.08 | n/m | 2026-07-21, From 2022-10-01 |
| 2022-09-30 | $0.15 | n/c | 2025-04-03, From 2021-10-01 |
| 2021-09-30 | $0.09 | -47.1% | 2024-02-15, From 2020-10-01 |
| 2020-09-30 | $0.17 | -5.6% | 2023-04-19, From 2019-10-01 |
| 2019-09-30 | $0.18 | n/a | 2022-10-13, From 2018-10-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| BGM Group Ltd. (BGM) | 2025-09-30 | -$0.18 | n/m |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | -$1.68 | n/m |
| Sunshine Biopharma Inc. (SBFM) | 2024-12-31 | -$7.32 | n/m |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $0.012 | +9.1% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | -$1.68 | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$1.04 | n/m |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | -$1.21 | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$4.19 | n/m |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | -$0.09 | n/m |
Compare BGM, LIFD, SBFM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗